Home
HAE
HAE News

Latest Haemonetics Corporation (HAE) News on February 22, 2025

Argus Research

4 days ago

HAE: Raising target price to $67.00

Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye

Simply Wall St.

9 days ago

Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye

Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

13 days ago

Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect

HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

Zacks

15 days ago

HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

Haemonetics Third Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

15 days ago

Haemonetics Third Quarter 2025 Earnings: Misses Expectations

Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ...

GuruFocus.com

15 days ago

Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ...

Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

16 days ago

Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Haemonetics (HAE) Q3 Earnings Meet Estimates

Zacks

16 days ago

Haemonetics (HAE) Q3 Earnings Meet Estimates

Associated Press Finance

16 days ago

Haemonetics: Fiscal Q3 Earnings Snapshot

MT Newswires

16 days ago

Haemonetics Fiscal Q3 Adjusted Earnings, Revenue Increase; Adjusts 2025 Guidance

Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates

StockStory

16 days ago

Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

PR Newswire

16 days ago

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow

StockStory

17 days ago

Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow

Haemonetics Corp (HAE) Q3 2025 Earnings Report Preview: What To Look For

GuruFocus.com

17 days ago

Haemonetics Corp (HAE) Q3 2025 Earnings Report Preview: What To Look For

Argus Research

18 days ago

HAE: What does Argus have to say about HAE?

Is Omnicell Stock a Solid Pick for Your Portfolio Right Now?

Zacks

22 days ago

Is Omnicell Stock a Solid Pick for Your Portfolio Right Now?

Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up

Zacks

23 days ago

Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up

DGX Stock Dips Despite Q4 Earnings and Revenue Beat, Margins Rise

Zacks

23 days ago

DGX Stock Dips Despite Q4 Earnings and Revenue Beat, Margins Rise

Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?

Zacks

23 days ago

Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now?

Argus Research

25 days ago

HAE: Lowering target price to $72.00

CALID Arm Growth to Support Bruker Shares Amid Macro Issues

Zacks

a month ago

CALID Arm Growth to Support Bruker Shares Amid Macro Issues

Here's Why Haemonetics (HAE) is a Strong Value Stock

Zacks

a month ago

Here's Why Haemonetics (HAE) is a Strong Value Stock

Is Thermo Fisher Stock Worth Holding on to in Your Portfolio?

Zacks

a month ago

Is Thermo Fisher Stock Worth Holding on to in Your Portfolio?

IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch

Zacks

a month ago

IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch

Strategic Acquisitions to Support STERIS Stock Amid Macro Issues

Zacks

a month ago

Strategic Acquisitions to Support STERIS Stock Amid Macro Issues

Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market

Zacks

a month ago

Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

Zacks

a month ago

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

Argus Research

a month ago

HAE: Lowering target price to $79.00

Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

Zacks

a month ago

Globus Medical Surges 62.1% in a Year: What's Driving the Stock?

HAE or ABT: Which Is the Better Value Stock Right Now?

Zacks

a month ago

HAE or ABT: Which Is the Better Value Stock Right Now?

Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock

Zacks

a month ago

Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?

Zacks

a month ago

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?

Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Zacks

a month ago

Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Should Edwards Lifesciences Stock Stay in Your Portfolio Now?

Zacks

a month ago

Should Edwards Lifesciences Stock Stay in Your Portfolio Now?

IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes

Zacks

a month ago

IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes

NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls

Zacks

a month ago

NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls

Argus Research

a month ago

HAE: Raising target price to $84.00

Macroeconomic Woes, Competition Weigh on TMO's Stock Performance

Zacks

a month ago

Macroeconomic Woes, Competition Weigh on TMO's Stock Performance

MT Newswires

a month ago

Haemonetics Completes $67.8 Million Sale of Whole Blood Assets to GVS

BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope

Zacks

a month ago

BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

PR Newswire

a month ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

WBA Q1 Earnings and Revenues Beat Estimates, Stock Up in Pre-Market

Zacks

a month ago

WBA Q1 Earnings and Revenues Beat Estimates, Stock Up in Pre-Market

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

Zacks

a month ago

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

PR Newswire

a month ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Zacks

a month ago

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Should Exact Sciences Stock Stay in Your Portfolio Right Now?

Zacks

a month ago

Should Exact Sciences Stock Stay in Your Portfolio Right Now?

ILMN Stock Set to Gain From Latest Updates to the NovaSeq X Series

Zacks

a month ago

ILMN Stock Set to Gain From Latest Updates to the NovaSeq X Series

Should National Vision Stock Be in Your Portfolio Right Now?

Zacks

2 months ago

Should National Vision Stock Be in Your Portfolio Right Now?

Veracyte Gains 44% in a Year: What's Driving the Stock?

Zacks

2 months ago

Veracyte Gains 44% in a Year: What's Driving the Stock?

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

2 months ago

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

HAE vs. ABT: Which Stock Is the Better Value Option?

Zacks

2 months ago

HAE vs. ABT: Which Stock Is the Better Value Option?

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Zacks

2 months ago

Macroeconomic Woes, FX Headwind Drag NEOG Stock Down

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Zacks

2 months ago

Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Zacks

2 months ago

Should You Retain Labcorp Stock in Your Portfolio Right Now?

Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes

Zacks

2 months ago

Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes

Should You Retain Charles River Stock in Your Portfolio Now?

Zacks

2 months ago

Should You Retain Charles River Stock in Your Portfolio Now?

Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?

Zacks

2 months ago

Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?

Should You Hold Quest Diagnostics Stock in Your Portfolio Now?

Zacks

2 months ago

Should You Hold Quest Diagnostics Stock in Your Portfolio Now?

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

Zacks

2 months ago

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

Growing Biosimilars Business, New Partnerships Support ABT Stock

Zacks

2 months ago

Growing Biosimilars Business, New Partnerships Support ABT Stock

Should You Hold Align Technology Stock in Your Portfolio Right Now?

Zacks

2 months ago

Should You Hold Align Technology Stock in Your Portfolio Right Now?

Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock

Zacks

2 months ago

Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Zacks

2 months ago

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Here's Why You Should Add HAE Stock to Your Portfolio Now

Zacks

2 months ago

Here's Why You Should Add HAE Stock to Your Portfolio Now

Reasons to Add GMED Stock to Your Portfolio Right Now

Zacks

2 months ago

Reasons to Add GMED Stock to Your Portfolio Right Now

Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?

Zacks

2 months ago

Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?

Argus Research

2 months ago

HAE: Lowering target price to $81.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE)

Zacks

2 months ago

Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE)

Should You Retain Teleflex Stock in Your Portfolio Right Now?

Zacks

2 months ago

Should You Retain Teleflex Stock in Your Portfolio Right Now?

Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs

Zacks

2 months ago

Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?

Zacks

2 months ago

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?

Investors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growth

Simply Wall St.

2 months ago

Investors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growth

MYGN Stock Might Gain From the New Recognition of RiskScore Study

Zacks

2 months ago

MYGN Stock Might Gain From the New Recognition of RiskScore Study

Reasons to Ratain CVS Stock in Your Portfolio Now

Zacks

2 months ago

Reasons to Ratain CVS Stock in Your Portfolio Now

Reasons to Retain ABT Stock in Your Portfolio Now

Zacks

2 months ago

Reasons to Retain ABT Stock in Your Portfolio Now

Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?

Zacks

2 months ago

Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Zacks

2 months ago

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

HAE or SYK: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

HAE or SYK: Which Is the Better Value Stock Right Now?

ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

Zacks

2 months ago

ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

Argus Research

2 months ago

HAE: Lowering target price to $86.00

Reasons to Retain STE Stock in Your Portfolio Now

Zacks

2 months ago

Reasons to Retain STE Stock in Your Portfolio Now

Bioproduction Prospects to Drive TMO Shares Despite Macroeconomic Woes

Zacks

2 months ago

Bioproduction Prospects to Drive TMO Shares Despite Macroeconomic Woes

SNN Stock Might Rise Following FDA Nod for AETOS Stemless

Zacks

2 months ago

SNN Stock Might Rise Following FDA Nod for AETOS Stemless

LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal

Zacks

2 months ago

LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal

Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?

Zacks

2 months ago

Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?

Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Zacks

2 months ago

Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Zacks

2 months ago

Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?

Reasons to Retain Alcon Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain Alcon Stock in Your Portfolio for Now

Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes

Zacks

2 months ago

Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?

Zacks

2 months ago

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?

Reasons to Retain Envista Stock in Your Portfolio for Now

Zacks

2 months ago

Reasons to Retain Envista Stock in Your Portfolio for Now

Should You Continue to Hold TMO Stock in Your Portfolio?

Zacks

2 months ago

Should You Continue to Hold TMO Stock in Your Portfolio?

Argus Research

2 months ago

HAE: Lowering target price to $88.00

New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

Zacks

2 months ago

New NCCN Guidelines Boost Myriad Genetics' Prolaris: Stock to Gain?

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Zacks

2 months ago

QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements

Should You Continue to Retain Insulet Stock in Your Portfolio Now?

Zacks

2 months ago

Should You Continue to Retain Insulet Stock in Your Portfolio Now?

Are Investors Undervaluing Haemonetics (HAE) Right Now?

Zacks

3 months ago

Are Investors Undervaluing Haemonetics (HAE) Right Now?

Reasons to Retain ZBH Stock in Your Portfolio for Now

Zacks

3 months ago

Reasons to Retain ZBH Stock in Your Portfolio for Now

Share on Social Networks: